Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance ...

An international drug ring accused of trafficking ketamine into Australia has been dismantled in Europe with the help of the Australian Federal Police. Eleven people have been charged in the alleged ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.

The Lamb of God frontman called the tech billionaire a "complete asshole." Randy Blythe Rips Elon Musk: He’s President Trump’s “Ketamine-Fueled Pet Rocket Monkey” ...

The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.

This article explores insights from Richmond-area therapists on Ketamine-Assisted Psychotherapy (KAP) and EMDR therapy, focusing on their applications in treating trauma, CPTSD, and mental health ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

A fatal medication error and subsequent involuntary manslaughter charge highlights the ongoing challenges of error reporting in EMS ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...